Sabinsa Secures Patent for Saberry-Cococin Formulation


The formula is intended for dermal papilla protection.

Sabinsa Corp. (East Windsor, NJ) has earned a U.S. patent for its combined formula of Saberry and Cococin. Saberry is a proprietary extract of amla fruit (Indian gooseberry), standardized for beta-glucogallin. Cococin is patented freeze-dried coconut water solids that are free of sugars and carbs. The formula is intended to protect the dermal papilla cells from stress signals.

Related Videos
Nils Hoem and Nutritional Outlook editor Sebastian Krawiec
Related Content
© 2024 MJH Life Sciences

All rights reserved.